ArticleInternational journal of obesity (2005)2025
Consumption of methyl donor nutrients and incidence of obesity: is the association influenced by parent's obesity? Results of 4 years of follow-up of the CUME study.
Article in International journal of obesity (2005), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDNA methylation is labile to the consumption of methyl donor nutrients (MetD), and may modulate gene expression associated with obesity.
objectiveTo evaluate the association between MetD consumption and the incidence of obesity, as well as to test the modifying role of the effect of the family history of the disease in this association. METHODOLOGY: This longitudinal study, with 1205 participants of the Cohort of Universities of Minas Gerais (CUME study), evaluated the incidence of obesity in a 4-year follow-up (2016- 2020). The intake of MetD nutrients (B2, B6, B9, B12, choline, betaine, and methionine) was estimated through a semi-quantitative food frequency questionnaire validated for the population. A MetD score was calculated and later stratified into low, intermediate, and high scores according to the tertiles of the sample. The presence of father and mother with obesity and parental obesity (father and mother with the disease) was self-reported. Associations were tested by Cox regression.
results89 (7.4%) cases of obesity were identified during follow-up. Participants who were in the third quartile of B2 consumption and the second quartile of B9 and choline consumption presented 60% (95%CI: 0.20-0.79), 52% (95%CI: 0.26-0.89) and 52% (95%CI: 0.24-0.93) less risk of developing obesity, respectively. Presenting an intermediate MetD score was also associated with a lower risk for the outcome (HR: 0.40; 95%CI: 0.18-0.84). However, the association between high MetD score and obesity incidence was observed only among individuals with a history of the disease in the father (HR: 0.19; 95%CI: 0.03-0.98; p-interaction = 0.022).
conclusionIntermediate consumption of B2, B9, and choline was associated with a lower risk of obesity, while a high MetD score was associated with reduced risk of outcome in those with a history of paternal obesity.
Indexed as
Identifiers
40634683What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.